市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 看涨 |
| Biotechnology (全球的) | 混合的 | 看涨 | |
| 股票 | Veru Inc. | 混合的 | 看涨 |
AIStockmoo 评分
| 分析师共识 | 0.0 |
| 内部交易活动 | NA |
| 价格波动 | 1.5 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | -2.5 |
| 相对估值 | NA |
| 财务健康 | 0.0 |
| 宏观环境 | -2.8 |
| AI Insight | NA |
| AI Technical | NA |
| 平均 | -0.24 |
|
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Value |
| 内部持股比例 | 14.19% |
| 机构持股比例 | 33.43% |
该时间范围内无数据。
该时间范围内无数据。
| 5年平均股息收益率 | 0.00% |
| 除息日 | 公告日期 | 支付日期 | 详情 |
|---|---|---|---|
| 28 Apr 2014 | 24 Mar 2014 | 07 May 2014 | 0.07 现金 |
| 27 Jan 2014 | 16 Dec 2013 | 05 Feb 2014 | 0.07 现金 |
| 28 Oct 2013 | 03 Oct 2013 | 06 Nov 2013 | 0.07 现金 |
| 29 Jul 2013 | 15 Jul 2013 | 07 Aug 2013 | 0.07 现金 |
| 28 Jan 2013 | 03 Jan 2013 | 06 Feb 2013 | 0.06 现金 |
每年股息收益率
| 年份 | 每年总股息 ($) | 频率/年份 | 收益率 % |
|---|---|---|---|
| 2014 | 0.140 | 2 | 0.36 |
| 2013 | 0.200 | 3 | 0.24 |
投资组合